Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Silvio, Orlando"'
1
Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?
Autor: Donato Lacedonia, Grazia Pia Palladino, Maria P. Foschino-Barbaro, Giovanna Elisiana Carpagnano, Silvio Orlando, Anna Koutelou, Domenico Martinelli
Publikováno v: European Journal of Clinical Investigation. 42:478-486
Eur J Clin Invest 2012; 42 (5): 478–486 Abstract Background Today an increasing interest is being generated by the study of lung cancer markers in the exhaled breath condensate (EBC), precisely because this sample seems to lend itself to lung cance
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b884aed54cf77fa9a8e704ee779ebcfc
https://doi.org/10.1111/j.1365-2362.2011.02603.x
Zobrazit plný text záznamu
2
Exhaled matrix metalloproteinase-9 in lung cancer
Autor: Donato Lacedonia, Maria P. Foschino-Barbaro, Giovanna Elisiana Carpagnano, Domenico Martinelli, Silvio Orlando, Grazia Pia Palladino
Publikováno v: Rejuvenation research. 15(4)
Matrix metalloproteinase-9 (MMP-9) has been recognized in several types of tumor development and progression, including lung cancer, for its role in the degradation and remodeling of lung tissue. Furthermore, increased MMP-9 has been commonly describ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925597a748c7fbff4d3fd004af2740fb
https://pubmed.ncbi.nlm.nih.gov/22877564
Zobrazit plný text záznamu
3
Microsatellite alterations and cell-free DNA analysis: could they increase the cytology sensitivity in the diagnosis of malignant pleural effusion?
Autor: Grazia Pia Palladino, Domenico Martinelli, Donato Lacedonia, Silvio Orlando, Elio Costantino, Maria P. Foschino-Barbaro, Giovanna Elisiana Carpagnano
Publikováno v: Rejuvenation research. 15(3)
The exact diagnosis of malignant pleural effusions (PE) is difficult and often requires combined procedures, because the cytological examination of pleural fluid does not detect tumoral cells in 40% of malignant effusion cases. The aim of this study
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b66a8776e1bbcb1e10567a59cc93487
https://pubmed.ncbi.nlm.nih.gov/22551519
Zobrazit plný text záznamu
4
Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?
Autor: Giovanna E, Carpagnano, Donato, Lacedonia, Grazia P, Palladino, Anna, Koutelou, Domenico, Martinelli, Silvio, Orlando, Maria P, Foschino-Barbaro
Publikováno v: European journal of clinical investigation. 42(5)
Today an increasing interest is being generated by the study of lung cancer markers in the exhaled breath condensate (EBC), precisely because this sample seems to lend itself to lung cancer early screening and follow-up. Indeed, ferritin and superoxi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::953c14ffc92a6beab6906cfc08eb9c71
https://pubmed.ncbi.nlm.nih.gov/21955247
Zobrazit plný text záznamu
5
Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8
Autor: Maria P. Foschino-Barbaro, Anna Koutelou, Donato Lacedonia, Grazia Pia Palladino, Giovanna Elisiana Carpagnano, Silvio Orlando
Publikováno v: BMC Cancer, Vol 11, Iss 1, p 226 (2011)
BMC Cancer
Background Recent advances in lung cancer biology presuppose its inflammatory origin. In this regard, LTB-4 and IL-8 are recognized to play a crucial role in neutrophil recruitment into airways during lung cancer. Notwithstanding the intriguing hypot
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2337e74fe55e098bfbfa854efc61f996
http://www.biomedcentral.com/1471-2407/11/226
Zobrazit plný text záznamu
6
Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer
Autor: Silvio Orlando, Mario De Lena, Saverio Cinieri, Vito Lorusso, Gaetano Di Rienzo, Cosimo Brunetti, Mario Luigi Cisternino, Gaetano Napoli, Francesco Carpagnano, N. Panza, Salvatore Palazzo, Giuseppe Frasci
Publikováno v: Scopus-Elsevier
PURPOSE: To determine the maximum-tolerated dose of gemcitabine when combined with a fixed dose of vinorelbine in the treatment of non–small-cell lung cancer (NSCLC) and to evaluate in a phase II trial the activity of this combination. PATIENTS AND
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::960c7855946abaf1786dd97d25230823
https://pubmed.ncbi.nlm.nih.gov/10637256
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje